FEBRUARY 21-22, 2017: 2nd Annual Biosimilars Summit

Discussions on key insights from thought leaders into the biggest challenges in the analytical and clinical phases of biosimilar drug development, from addressing current regulatory struggles, demonstrating the quality attributes needed to prove interchangeability, and successfully entering the market.

Please to read the entire article.